France
Astraveus, founded in 2016 and headquartered in France, operates at the intersection of Biotechnology, Life Sciences, and Clean Energy. The company’s slogan, "We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies," effectively encapsulates its mission and innovation in the life sciences sector.
With its advancements, Astraveus is poised to be a significant player in the evolving landscape of cell and gene therapies. Its proprietary technology aims to streamline the manufacturing process, facilitating more accessible and efficient therapeutics production.
Recently, Astraveus secured a €7.10M Debt Financing investment as of 19 December 2024. This financial injection highlights investor confidence in the market potential of the company's high-tech solutions. Despite the absence of disclosed investor names, the substantial funding underscores Astraveus' strategic position and growth trajectory in this rapidly expanding field.
